WO2004085604A1 - The use of n-acetyl glucosamine as additive in wine and wine comprising n-acetyl glucosamine - Google Patents

The use of n-acetyl glucosamine as additive in wine and wine comprising n-acetyl glucosamine Download PDF

Info

Publication number
WO2004085604A1
WO2004085604A1 PCT/CN2004/000274 CN2004000274W WO2004085604A1 WO 2004085604 A1 WO2004085604 A1 WO 2004085604A1 CN 2004000274 W CN2004000274 W CN 2004000274W WO 2004085604 A1 WO2004085604 A1 WO 2004085604A1
Authority
WO
WIPO (PCT)
Prior art keywords
wine
acetylglucosamine
test
acceptable derivative
acetyl glucosamine
Prior art date
Application number
PCT/CN2004/000274
Other languages
French (fr)
Chinese (zh)
Inventor
Qiwang Xu
Junkang Liu
Zetao Yuan
Original Assignee
Third Military Medical University, Chinese People's Liberation Army, P.R. Of China
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Third Military Medical University, Chinese People's Liberation Army, P.R. Of China filed Critical Third Military Medical University, Chinese People's Liberation Army, P.R. Of China
Publication of WO2004085604A1 publication Critical patent/WO2004085604A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12GWINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
    • C12G1/00Preparation of wine or sparkling wine

Definitions

  • N-acetylglucosamine as an additive in wine and wine containing N-acetylglucosamine
  • the present invention relates to the use of N-acetylglucosamine or an acceptable derivative of a wine product as an additive in wine, wine containing N-acetylglucosamine or an acceptable derivative of a wine product, and a method for preparing wine.
  • Another type of work is to add Chinese herbal medicines with health effects in wine.
  • This kind of alcohol is essentially only using alcohol as a carrier for drugs, not for the purpose of reducing drinking damage.
  • N-acetylglucosamine or acceptable derivatives of alcoholic products are added to wine in an appropriate proportion and drunk.
  • the crowd test shows that the symptoms of dizziness are significantly reduced, the drunken response does not occur or it is postponed after increasing the amount of drinking, and can effectively calm Subsequent drunk reactions after drinking wine, such as thirst, poor language expression, and general discomfort.
  • the inventors established a model of biological wave growth in the research of biological wave theory, and further studied the molecular mechanism of biological wave growth, and put forward the principle of micro-heterogeneous changes in the biological wave of biological organisms.
  • the speed of biological wave changes is fast or slow, depending on the degree of change in the external environment.
  • the rapidly changing environment After receiving the harmful substances to stimulate the body, the rapidly changing environment has led to a heterologous micro occurs, so that imbalance between the body 5 and the environment caused by such damage occurs and symptoms of injury or systemic symptoms of local molecular biology
  • proteins, especially various enzymes are unstable or even lose function under changed conditions, especially temperature changes and the presence of microbial metabolites.
  • Still another object of the present invention is to provide a method for preparing wine, comprising the step of adding N-acetylglucosamine or an acceptable derivative thereof to a raw wine to prepare a finished wine.
  • N-acetylglucosamine N-acetyl-D-glucosamine
  • molecular formula C 8 H 15 N0 6
  • structural formula (I) is expressed as follows:
  • N-acetyl-D-glucosamine examples include, but are not limited to: salts with inorganic acids, such as hydrochloride phosphate hydrogen phosphate, and organic salts with acids such as citraconic acid sample benzoate, ascorbate ⁇
  • N-acetyl-D-glucosamine or an acceptable derivative thereof can be directly added to the raw wine to prepare a finished wine.
  • N-acetyl-D-glucosamine or an acceptable derivative thereof can be added to the raw wine in the form of an aqueous solution.
  • N-acetyl-D-glucosamine or an acceptable derivative thereof can be packaged in combination with the wine composition and added to the wine before it is consumed by the drinker.
  • the wine suitable for the purpose of the present invention may be any wine, such as, for example, raw grape wine, distilled wine such as dry red wine, dry white wine, and the like.
  • N-acetylglucosamine or acceptable derivatives of alcoholic products in wine The content may be from 0.001 g / 100 ml to 10 g / 100 ml, preferably from 0.01 g / 100 ml to 5 g / 100 ml.
  • N-acetylglucosamine or an acceptable derivative of alcoholic products is used as an additive in wine, which can control the damage of harmful substances such as ethanol in the wine to the body, and the effective rate can reach more than 95%.
  • Proteus mirabilis should meet the following biochemical response characteristics: motility (+), urease (+), lactose (-), glucose (+), H 2 S (-), phenylalanine deaminase (+ ).
  • LB medium Improved LB medium (Composition: 1% tryptone, 0.5% yeast extract, 1% sodium chloride ⁇ . 1% glucose, 2% TTC, pH 7.2-7. 4 ⁇ 1.3 Test method:
  • Test sample A compound of formula (I) with a final concentration of 0.5% was added to the LB plate, and Proteus mirabilis was spotted in the same way, and cultured for 9 hours at 37 ° C.
  • This test uses a biological wave test model to study the compounds of formula (I).
  • the compound of formula (I) can not only make bacterial cells show normal biological wave characteristics, but also make this fluctuation show a more subtle fluctuation mode, indicating that the compound of formula (I) can promote biological fluctuations. .
  • This wave-promoting effect helps explain the effect of N-acetylglucosamine or an acceptable derivative thereof in controlling damage after drinking.
  • Acute toxicology test including oral, intravenous and maximum dose test
  • a commercially available wine (alcohol content of 12 degrees) was administered to the control group of mice; the wine of the present invention (that is, wine alcohol content: 12 degrees and N-acetylglucosamine content of 0.1% by weight) was used to administer the experimental group of mice Gavage, test group and control group Experiments were performed on 30 mice each.
  • the rats When administered at a dose of 0.2ml / 20g / times (that is, 0.2ml wine per 20g mouse weight), the rats were fed every 10 minutes.
  • 18 mice in the control group fainted within 1 hour and lost consciousness.
  • Nine rats were unstable and 3 died; when the test group reached this dose, 2 rats were unconscious, 4 rats showed slight standing instability, and the remaining rats were basically normal.
  • the results of the control group and the test group were quite different.
  • Test wine composition 0.1% by weight of N-acetylglucosamine was added to the commercially available wine. The test subjects generally responded well, 45 of them reported no dizziness, including 23 of them who reported that the drunken response was lighter after drinking and the total effective rate was over 90%.
  • a commercially available wine + 0.1% by weight of N-acetylglucosamine hydrochloride was used for the test, and similar results were obtained, of which 46 people reported no dizziness, including 23 people who reported a lighter drunk response after drinking 5 and the total effective rate was more than 2%.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present provides the use of N-acetyl glucosamine or alcoholic product acceptable derivatives as additive in wine, low damage wine that comprises N-acetyl glucosamine or alcoholic product acceptable derivatives and the method manufacturing the wine. N-acetyl glucosamine or alcoholic product acceptable derivatives as additive may can control the damage of injurious substance in the wine such as alcohol and the like to the body, the effective rate can be more than 95%.

Description

N -乙酰氨基葡萄糖作为添加剂在葡萄酒中的应用 及包含 N-乙酰氨基葡萄糖的葡萄酒 技术领域  Application of N-acetylglucosamine as an additive in wine and wine containing N-acetylglucosamine
本发明涉及 N-乙酰氨基葡萄糖或其酒类制品可接受的衍生 物作为添加剂在葡萄酒中的应用, 包含 N-乙酰氨基葡萄糖或其酒 类制品可接受的衍生物的葡萄酒及制备葡萄酒的方法。  The present invention relates to the use of N-acetylglucosamine or an acceptable derivative of a wine product as an additive in wine, wine containing N-acetylglucosamine or an acceptable derivative of a wine product, and a method for preparing wine.
技术背景  technical background
通常认为饮酒对人体的影响具有两面性。 适量饮酒可以舒筋 活血, 增加能量, 并有报道提出可对心血管疾病有防治作用。 但 所谓适量饮酒确实难以把握, 个体饮酒后反应不一。 过量饮酒的 常见症状有头暈、 头痛、 眩晕、 恶心、 呕吐、 食欲不正、 饮酒后 全身乏力 口渴等外观症状; 酒精以其脂溶性和亲水性对细胞膜 脂类及膜蛋白的构型 构象产生影响而造成对机体组织的损伤 5 大多见于肝脏和心脑血管的损伤。 人类为兼顾人们的饮酒传统习 惯和减少对人体损伤而进行了大量的探索, 但大多集中在酒制备 工艺的改造上 还有的是在酒中加入一些中药材 9 以试围改善酒 的品盾, 减少对人体影响《» The effects of drinking on the human body are generally considered to be two-sided. Moderate drinking can relax muscles and promote blood circulation, increase energy, and it has been reported that it can prevent and cure cardiovascular diseases. However, the so-called moderate drinking is indeed difficult to grasp, and individual reactions vary after drinking. Common symptoms of excessive drinking include dizziness, headache, dizziness, nausea, vomiting, poor appetite, general weakness and thirst after drinking; alcohol has its lipid-soluble and hydrophilic properties to the conformational conformation of cell membrane lipids and membrane proteins impact damage caused by five pairs of body tissues mostly found in liver damage and cardiovascular. Human beings have done a lot of exploration in order to balance people's drinking traditions and reduce damage to the human body, but most of them focus on the transformation of the wine preparation process, and some are adding some Chinese medicinal materials 9 to the wine to try to improve the taste of the wine, reduce Impact on the human body "»
在酒的加工过程去除杂醇为多见的改善酒品质的方式, 但这 只是在一定程度上减少酒精以外的成份对机体的影响 s 防止乙醇 对机体损伤的方法是降低乙醇的含量, 这在一定程度上起到了一 些积极的作用。 但乙醇进入人体后特别是在其饮用量超过一定限 度时, 对机体的损伤仍然是非常明显的, 这不论在白酒、 葡萄酒 或啤酒中都是如此。 In the process liquor is removed fusel ways to improve the quality of the wine more common, but only reduce the influence of components other than alcohol on the body to some extent s of the body to prevent injury of the ethanol method is to reduce the ethanol content, in which To some extent, it has played some positive roles. However, after ethanol enters the human body, especially when the amount of alcohol consumed exceeds a certain limit, the damage to the body is still very obvious, which is true whether it is in white wine, wine or beer.
另有一类工作是在酒中加入有保健效果的中药材。 这种酒类 实质上只是将酒作为药物的载体而不是以消减饮酒损伤为目的。  Another type of work is to add Chinese herbal medicines with health effects in wine. This kind of alcohol is essentially only using alcohol as a carrier for drugs, not for the purpose of reducing drinking damage.
现已发现, 在饮用葡萄酒过量时脑神经的反应更为明显。 这 是由于葡萄酒中丙酮等杂质对机体细胞亲和力强, 抑制了体内解 酒系统或者是酶的工作。 本发明人在研究工作中偶然发现, 当把It has been found that the response of the brain nerves is more pronounced when drinking wine in excess. This It is because impurities such as acetone in wine have a strong affinity for body cells, which inhibits the hangover system or the work of enzymes in the body. The inventor discovered by accident in research work that when
N-乙酰氨基葡萄糖或其酒类制品可接受的衍生物以适当比例添加 在葡萄酒中后饮用, 人群试验反映头暈症状显著减轻, 醉酒反应 不发生或增加饮用量后推迟发生, 且能有效地平緩饮用葡萄酒后 的后续醉酒反应, 如口渴、 语言表达不佳以及全身无力等不适反 应。 N-acetylglucosamine or acceptable derivatives of alcoholic products are added to wine in an appropriate proportion and drunk. The crowd test shows that the symptoms of dizziness are significantly reduced, the drunken response does not occur or it is postponed after increasing the amount of drinking, and can effectively calm Subsequent drunk reactions after drinking wine, such as thirst, poor language expression, and general discomfort.
本发明人在进行生物波理论研究中建立了生物波动生长的模 型, 并进一步深入研究了生物波动生长的分子机制, 提出了生物 有机体的生物波不断改变的微异源变化原理。 生物波变化的速度 有快有慢, 取决于外来环境的改变程度。 机体接受有害物质刺激 后, 内环境出现了迅速变化, 促成微异源性发生, 使机体与环境 之间失衡5 引起局部的损伤或全身中毒症状 这种损伤和中毒症 状的出现从分子生物学角度来分析, 是由于蛋白特别是各种酶类 在改变了的条件下, 特别是温度改变和微生物代谢产物存在奈件 下, 功能不稳定甚至功能丧失。 The inventors established a model of biological wave growth in the research of biological wave theory, and further studied the molecular mechanism of biological wave growth, and put forward the principle of micro-heterogeneous changes in the biological wave of biological organisms. The speed of biological wave changes is fast or slow, depending on the degree of change in the external environment. After receiving the harmful substances to stimulate the body, the rapidly changing environment has led to a heterologous micro occurs, so that imbalance between the body 5 and the environment caused by such damage occurs and symptoms of injury or systemic symptoms of local molecular biology The reason for this is that proteins, especially various enzymes, are unstable or even lose function under changed conditions, especially temperature changes and the presence of microbial metabolites.
饮酒后肝脏细胞代谢受到抑制9 非特异性炎症发生 s 局部分 泌物增加 细胞肿大甚至出现混浊肿或坏死 β 据信, Ν-乙酰氨基 葡萄糖作为一个生物波调控因子, 可以稳定大分子物质的振荡, 维持生理振荡不停地进行, 减緩和排斥机体存在的不利因素的影 响, 从而维持蛋白特别是各种酶类的生理功能, 减低饮酒损伤。 Liver cell metabolism after drinking 9 non-specific inhibition of inflammation s local secretion cloudy swelling increases cell necrosis or swelling even believed β, Ν- acetyl glucosamine as a regulating factor of biological wave, stable oscillation can be macromolecules, The maintenance of physiological oscillations continues to slow down and repel the influence of adverse factors existing in the body, thereby maintaining the physiological functions of proteins, especially various enzymes, and reducing drinking damage.
目前尚未有有效地控制饮酒损伤的措施和药物。 在这种情况 下, 本发明人惊异地发现, Ν -乙酰基 - D -氨基葡萄糖或其酒类 制品可接受的衍生物作为添加剂制备成的新型葡萄酒, 可有效降 低饮酒损伤。  There are currently no effective measures and drugs to control drinking damage. Under this circumstance, the inventors have surprisingly found that a novel wine prepared by using N-acetyl-D-glucosamine or an acceptable derivative thereof as an additive can effectively reduce drinking damage.
发明内容  Summary of the Invention
本发明的一个目的是提供 Ν-乙酰氨基葡萄糖或其酒类制品 可接受的衍生物作为添加剂在葡萄酒中的应用。 It is an object of the present invention to provide N-acetylglucosamine or a wine product thereof. Use of acceptable derivatives as additives in wine.
本发明的另一个目的是提供包含 N-乙酰氨基葡萄糖或其酒 类制品可接受的衍生物的葡萄酒。  It is another object of the present invention to provide wines containing N-acetylglucosamine or an acceptable derivative thereof.
本发明的又一个目的是提供一种制备葡萄酒的方法, 包括向 原料葡萄酒中加入 N-乙酰氨基葡萄糖或其酒类制品可接受的衍 生物以制备成品葡萄酒的步骤。  Still another object of the present invention is to provide a method for preparing wine, comprising the step of adding N-acetylglucosamine or an acceptable derivative thereof to a raw wine to prepare a finished wine.
所述的 N-乙酰氨基葡萄糖的全名为 N-乙酰基 -D-氨基葡 萄糖, 分子式为 C8H15N06, 结构式 (I)表示如下: The full name of the N-acetylglucosamine is N-acetyl-D-glucosamine, the molecular formula is C 8 H 15 N0 6 , and the structural formula (I) is expressed as follows:
Figure imgf000004_0001
可用于本发明的 N-乙酰基 -D-氨基葡萄糖的酒类制品可 接受的衍生物的实例包括但不限于: 与无机酸形成的盐, 如盐酸 盐 磷酸盐 磷酸氢益, 以及与有机酸形成的盐 如柠樣酸盐 苯甲酸盐、 抗坏血酸盐 β
Figure imgf000004_0001
Examples of acceptable derivatives of N-acetyl-D-glucosamine for use in the present invention include, but are not limited to: salts with inorganic acids, such as hydrochloride phosphate hydrogen phosphate, and organic salts with acids such as citraconic acid sample benzoate, ascorbate β
Ν-乙酰基 -D-氨基葡萄糖或其酒类制品可接受的衍生物 一般可直接加入到原料葡萄酒中制备成成品葡萄酒。 或者, Ν- 乙酰基 - D -氨基葡萄糖或其酒类制品可接受的衍生物可以以水 溶液的形式加入到原料葡萄酒中。或者, Ν-乙酰基 -D-氨基葡 萄糖或其酒类制品可接受的衍生物可以与葡萄酒组成联合包装, 在饮用者饮用前加入到葡萄酒中。  N-acetyl-D-glucosamine or an acceptable derivative thereof can be directly added to the raw wine to prepare a finished wine. Alternatively, N-acetyl-D-glucosamine or an acceptable derivative thereof can be added to the raw wine in the form of an aqueous solution. Alternatively, N-acetyl-D-glucosamine or an acceptable derivative thereof can be packaged in combination with the wine composition and added to the wine before it is consumed by the drinker.
适用于本发明目的的葡萄酒可以是任何葡萄酒, 例如原汁葡 萄酒、 蒸馏葡萄酒如干红葡萄酒、 干白葡萄酒等。  The wine suitable for the purpose of the present invention may be any wine, such as, for example, raw grape wine, distilled wine such as dry red wine, dry white wine, and the like.
Ν-乙酰氨基葡萄糖或其酒类制品可接受的衍生物在葡萄酒中 的含量可以为 O.OOlg/lOOml 至 10g/100ml, 优选为 O.Olg/lOOml 至 5g/100ml。 N-acetylglucosamine or acceptable derivatives of alcoholic products in wine The content may be from 0.001 g / 100 ml to 10 g / 100 ml, preferably from 0.01 g / 100 ml to 5 g / 100 ml.
N-乙酰氨基葡萄糖或其酒类制品可接受的衍生物作为添加剂 应用于葡萄酒中,可控制葡萄酒中乙醇等有害物质对机体的损害, 有效率可达 95%以上。  N-acetylglucosamine or an acceptable derivative of alcoholic products is used as an additive in wine, which can control the damage of harmful substances such as ethanol in the wine to the body, and the effective rate can reach more than 95%.
具体实施方式  detailed description
下面结合实施例进一步说明本发明及其有益效果, 但是应该 明白, 这些实施例仅是为了举例说明本发明, 而不在任何方面构 成对本发明范围的限制。  The present invention and its beneficial effects are further described below with reference to the examples, but it should be understood that these examples are only for the purpose of illustrating the present invention and do not limit the scope of the present invention in any respect.
实施例 1. 式 (I )化合物的促波试验  Example 1. Wave-promoting test of a compound of formula (I)
1、 试验材料和方法:  1.Test materials and methods:
1.1 样品: 式 (I )化合物纯品  1.1 Sample: pure compound of formula (I)
1.2 试验材料:  1.2 Test materials:
菌种: 奇异变形杆菌应符合如下生化反应特征: 动力 (+)、 尿 素酶 (+)、 乳糖(-)、 葡萄糖 (+)、 H2S( - )、 苯丙氨酸脱氨酶 (+)。 Strains: Proteus mirabilis should meet the following biochemical response characteristics: motility (+), urease (+), lactose (-), glucose (+), H 2 S (-), phenylalanine deaminase (+ ).
培养基: 改良 LB培养基(组成成分: 1 %胰蛋白胨、 0.5%酵 母提取物 1 %氯化钠 ©。1%葡萄糖 謹 2%TTC ΡΗ7.2-7。4 λ 1.3 试验方法:  Medium: Improved LB medium (Composition: 1% tryptone, 0.5% yeast extract, 1% sodium chloride ©. 1% glucose, 2% TTC, pH 7.2-7. 4 λ 1.3 Test method:
对照样: 在 LB平板中心点种奇异变形杆菌, 37 培养 9小 时;  Control: Proteus mirabilis was spotted at the center of the LB plate and cultured for 9 hours at 37;
试验样: 在 LB平板中加入终浓度为 0.5%的式 ( I )化合物, 同法点种奇异变形杆菌, 37 培养 9小时。  Test sample: A compound of formula (I) with a final concentration of 0.5% was added to the LB plate, and Proteus mirabilis was spotted in the same way, and cultured for 9 hours at 37 ° C.
2、 试验结果及评价:  2.Test results and evaluation:
在对照样中显示出不断向外扩展, 间隔 3小时的同心环; 在 试验样中, 不但形成每隔 3小时出现的同心环, 而且与对照相比, 在每条环上显示出许多细小的波动环。  In the control sample, concentric rings that continuously expanded outward at intervals of 3 hours were shown. In the test sample, not only formed concentric rings that appeared every 3 hours, but also compared with the control, many small rings were shown on each ring. Fluctuation ring.
本试验采用生物波波动试验模型, 用以研究式(I )化合物的 促波作用, 结果可见式(I )化合物不仅可以使细菌细胞表现正常 的生物波特征, 而且使这种波动表现出更加微细的波动方式, 表 明式(I )化合物对生物波动是有促进作用的。 这种促波作用有助 于解释 N-乙酰氨基葡萄糖或其酒类制品可接受的衍生物控制饮 酒后损伤的效果。 This test uses a biological wave test model to study the compounds of formula (I). As a result, it can be seen that the compound of formula (I) can not only make bacterial cells show normal biological wave characteristics, but also make this fluctuation show a more subtle fluctuation mode, indicating that the compound of formula (I) can promote biological fluctuations. . This wave-promoting effect helps explain the effect of N-acetylglucosamine or an acceptable derivative thereof in controlling damage after drinking.
实施例 2. 式 (I )化合物的毒理试验  Example 2. Toxicological test of compound of formula (I)
进行式 (I )化合物的毒理试驗, 包括:  Conducting a toxicological test of a compound of formula (I), including:
1、 急性毒理试验: 包括口服、 静脉注射和最大极限量给药试 验;  1. Acute toxicology test: including oral, intravenous and maximum dose test;
2、 Ames试验;  2.Ames test;
3、 小鼠骨髓细胞微核试验;  3. Micronucleus test of mouse bone marrow cells;
4、 鼠精子畸性试验;  4. Rat sperm abnormality test;
5、 小鼠睾丸染色体畸变试验;  5. Test for chromosomal aberrations in mice;
6¾ 慢性致死试验; 6 ¾ chronic lethal test;
7、 亚慢性毒性(90天喂养)试验;  7. Subchronic toxicity (90-day feeding) test;
8、 传统致畸试验;  8. Traditional teratogenic test;
试验结论表明: 式 (I )化合物急性毒性试验剂量超过 2g/kg 时, 仍未出现急性中毒反应; 在长期毒性试验中, 最高剂量巳达 到 lg/kg, 经四周试验观察, 未出现中毒反应; 在生殖试验中, 从常规剂量 7mg/kg喂小鼠, 经三次传代, 证明式(I )化合物对 小鼠受孕、 妊娠、 分娩、 哺乳及仔鼠发育均无影响。 这些试验证 明式 (I )化合物属无毒物质。 实施例 3. 动物试验  The test conclusions show that: when the acute toxicity test dose of the compound of formula (I) exceeds 2g / kg, there is still no acute poisoning reaction; in the long-term toxicity test, the highest dose 巳 reaches lg / kg, and after four weeks of observation, no poisoning reaction occurs; In a reproduction test, mice were fed from a conventional dose of 7 mg / kg and three passages proved that the compound of formula (I) had no effect on mouse conception, pregnancy, childbirth, lactation and pup development. These tests verify that the compounds of formula (I) are non-toxic. Example 3. Animal test
采用市售的葡萄酒(酒精度 12度)对对照组小白鼠进行灌胃; 采用本发明的葡萄酒(即葡萄酒酒精度: 12度和 N-乙酰氨基葡萄 糖的含量 0.1%重量)对试验组小白鼠进行灌胃, 试验组和对照組 各 30只小白鼠进行试验。 当以 0.2ml/20g/次 (即每次 20克小鼠 体重灌 0.2ml葡萄酒)的剂量灌胃,每 10分钟加喂一次, 结果对照 组小鼠在 1小时内 18只暈厥,失去知觉, 9只站立不稳, 3只死亡; 试验组达到此剂量时 2只鼠昏迷, 4只鼠出现轻微的站立不稳的状 态,其余鼠状态基本正常。 对照组和试验組结果差别较大。 实施例 4.人群饮用试验 A commercially available wine (alcohol content of 12 degrees) was administered to the control group of mice; the wine of the present invention (that is, wine alcohol content: 12 degrees and N-acetylglucosamine content of 0.1% by weight) was used to administer the experimental group of mice Gavage, test group and control group Experiments were performed on 30 mice each. When administered at a dose of 0.2ml / 20g / times (that is, 0.2ml wine per 20g mouse weight), the rats were fed every 10 minutes. As a result, 18 mice in the control group fainted within 1 hour and lost consciousness. Nine rats were unstable and 3 died; when the test group reached this dose, 2 rats were unconscious, 4 rats showed slight standing instability, and the remaining rats were basically normal. The results of the control group and the test group were quite different. Example 4. Crowd drinking test
50 例人体试用, 饮用量为个人常规饮用量, 50 亳升至 500 亳升不等。 试验葡萄酒组成:市售葡萄酒中加入 0.1%重量的 N- 乙酰氨基葡萄糖。试验者普遍反应较好,其中有 45人反映不头晕, 包括 23人反映饮酒后醉酒反应较轻, 总有效率 90%以上。  Fifty cases of humans were tried out. The drinking amount was the personal drinking amount, ranging from 50 to 500 liters. Test wine composition: 0.1% by weight of N-acetylglucosamine was added to the commercially available wine. The test subjects generally responded well, 45 of them reported no dizziness, including 23 of them who reported that the drunken response was lighter after drinking and the total effective rate was over 90%.
采用市售葡萄酒 + 0.2%重量的 N-乙酰氨基葡萄糖进行试验, 取得相似结果, 其中 48人反映不头暈 s 包括 35人反映饮酒后醉 酒反应较轻, 总有效率 96%以上 a Using a commercially available wine + N- acetylglucosamine 0.2% by weight was tested to obtain similar results, which do not reflect dizziness 48 s 35 includes a rear reflecting alcohol intoxication was mild, the total efficiency of more than 96% a
采用市售葡萄酒 + 0.1%重量的 N-乙酰氨基葡萄糖盐酸盐进 行试验, 取得相似结果, 其中 46人反映不头暈, 包括 23人反映 饮酒后醉酒反应较轻 5 总有效率 2%以上。 A commercially available wine + 0.1% by weight of N-acetylglucosamine hydrochloride was used for the test, and similar results were obtained, of which 46 people reported no dizziness, including 23 people who reported a lighter drunk response after drinking 5 and the total effective rate was more than 2%.

Claims

权 利 要 求 Rights request
1. N-乙酰氨基葡萄糖或其酒类制品可接受的衍生物作为添加 剂在葡萄酒中的应用。 1. Use of N-acetylglucosamine or an acceptable derivative of alcoholic product as an additive in wine.
2. 权利的要求 1的应用, 其中将 N-乙酰氨基葡萄糖或其酒类 制品可接受的衍生物加入酒体中制备成新型酒品。  2. The use according to claim 1, wherein N-acetylglucosamine or an acceptable derivative thereof is added to the wine body to prepare a new type of wine.
3. 权利的要求 1的应用, 其中在饮用葡萄酒前将 N-乙酰氨基 葡萄糖或其酒类制品可接受的衍生物加入葡萄酒中。  3. Use according to claim 1, wherein N-acetylglucosamine or an acceptable derivative thereof is added to the wine before drinking the wine.
4. 权利要求 1-3中任一项的应用, 其中 N-乙酰氨基葡萄糖或 其酒类制品可接受的衍生物在葡萄酒中的含量为 O.OOlg/lOOml至 10g/100ml„  4. The use according to any one of claims 1 to 3, wherein the content of N-acetylglucosamine or an acceptable derivative thereof in wine is from 0.0000 g / 100 ml to 10 g / 100 ml.
5. 权利要求 4的应用, 其中 N-乙酰氨基葡萄糖或其酒类制品 可接受的衍生物在葡萄酒中的含量为 0i)lg/100醒 1至 5g/l藝薩 L 5. The use according to claim 4, wherein the content of acceptable derivatives of N-acetylglucosamine or its alcoholic products in wine is 0i) lg / 100, 1 to 5 g / l artsac L
6. 包含 N-乙酰氨基葡萄糖或其酒类制品可接受的衍生物的葡 萄酒。 6. Grape wine containing N-acetylglucosamine or an acceptable derivative thereof.
7. 权利要求 6的葡萄酒, 其中 N-乙酰氨基葡萄糖或其酒类制 品可接受的衍生物在葡萄酒中的含量为 CLO lg/lWk 至 10g/100ml。  7. The wine of claim 6, wherein the content of N-acetylglucosamine or an acceptable derivative thereof in the wine is CLO lg / lWk to 10 g / 100 ml.
8. 权利要求 7的葡萄酒, 其中 N-乙酰氨基葡萄糖或其酒类制 品可接受的衍生物在葡萄酒中的含量为 O.Olg/lOOml至 5g/100mIo Wine of claim 7, wherein the content of N- acetylglucosamine or a derivative thereof in a pharmaceutically article alcoholic wine is O.Olg / lOOml to 5g / 100mI o
9. 一种制备葡萄酒的方法, 包括向原料葡萄酒中加入 N-乙酰 氨基葡萄糖或其酒类制品可接受的衍生物以制备成品葡萄酒的步 9. A method for preparing wine, comprising the step of adding N-acetylglucosamine or an acceptable derivative thereof to a raw wine to prepare a finished wine
PCT/CN2004/000274 2003-03-27 2004-03-29 The use of n-acetyl glucosamine as additive in wine and wine comprising n-acetyl glucosamine WO2004085604A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNA031082750A CN1534089A (en) 2003-03-27 2003-03-27 Application of N-acetylglucosamine as additive of grape wine and grape wine containing N-acetylglucosamine
CN03108275.0 2003-03-27

Publications (1)

Publication Number Publication Date
WO2004085604A1 true WO2004085604A1 (en) 2004-10-07

Family

ID=33035131

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2004/000274 WO2004085604A1 (en) 2003-03-27 2004-03-29 The use of n-acetyl glucosamine as additive in wine and wine comprising n-acetyl glucosamine

Country Status (2)

Country Link
CN (1) CN1534089A (en)
WO (1) WO2004085604A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1611895A4 (en) * 2003-03-27 2008-02-20 Univ Pla 3Rd Military Medical Use of n-acetyl-d-aminoglycosamine in treatment of organ lesions related to toxicosis of drugs or chemicals
WO2009007660A1 (en) 2007-07-04 2009-01-15 Mathieu Borge Liquid or paste compositions intended to provide elements essential for the synthesis and formation of proteoglycans, in particular, for the treatment of cartilage degradation

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102199513A (en) * 2011-03-01 2011-09-28 邱阳 Oxidation resistant health wine
CN106072653A (en) * 2015-05-02 2016-11-09 邓渝 The vegetable protein beverage of 2-Acetamido-2-deoxy-D-glucose and application thereof
CN106333314A (en) * 2015-07-09 2017-01-18 邓渝 Application of N-acetylglucosamine to honey product and honey product containing N-acetylglucosamine
CN112375633A (en) * 2020-11-26 2021-02-19 江苏双林海洋生物药业有限公司 Glucosamine wine and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1156175A (en) * 1996-12-27 1997-08-06 中国人民解放军第三军医大学 Health-care wine using N-acetyl-D-aminoglucose as additives

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1156175A (en) * 1996-12-27 1997-08-06 中国人民解放军第三军医大学 Health-care wine using N-acetyl-D-aminoglucose as additives

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HUANG GUANG-FU ET AL.: "The advance of polysaccharide biomedical materials chitin and chitosan", CHINESE BULLETIN OF MACROMOLECULE, no. 3, 2001, pages 43 - 49 *
LU YONG-ZHANG: "Magic chitoson", JIAN XI CHEMICAL INDUSTRY, no. 3, 1997, pages 34 - 35 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1611895A4 (en) * 2003-03-27 2008-02-20 Univ Pla 3Rd Military Medical Use of n-acetyl-d-aminoglycosamine in treatment of organ lesions related to toxicosis of drugs or chemicals
WO2009007660A1 (en) 2007-07-04 2009-01-15 Mathieu Borge Liquid or paste compositions intended to provide elements essential for the synthesis and formation of proteoglycans, in particular, for the treatment of cartilage degradation

Also Published As

Publication number Publication date
CN1534089A (en) 2004-10-06

Similar Documents

Publication Publication Date Title
JP6292725B2 (en) Lipopolysaccharide, lipopolysaccharide production method and lipopolysaccharide compound
Videla et al. Role of intestinal microflora in chronic inflammation and ulceration of the rat colon.
JP4754066B2 (en) Anti-joint disorder
JP2019506856A5 (en)
MX2011007550A (en) Clay interlaced yeast compositions and methods of utilizing the same.
WO2012016445A1 (en) Bacillus subtilis strain and uses thereof
AU774212B2 (en) Novel compositions and methods for reduction of effects of endophyte-infected forages
WO2004085604A1 (en) The use of n-acetyl glucosamine as additive in wine and wine comprising n-acetyl glucosamine
AU742460B2 (en) Fatty acids as a diet supplement
US9168274B1 (en) Method to reduce intoxication from ethanol in humans
WO2004085603A1 (en) The use of n-acetyl glucosamine as additive in beer and beer comprising n-acetyl glucosamine
Luo et al. Beta‐glucan from Agrobacterium sp. ZX09 improves growth performance and intestinal function in weaned piglets
WO2019109348A1 (en) Use of butyribacter intestini in preventing and/or treating inflammation-related diseases
WO2004084916A1 (en) Use of acetyl-d-aminoglycosamine in treatment of local lesions and systematic symptoms related to infections of virus or bacteria
WO2004093556A1 (en) The use of n-acetyl glucosamine as additive in milk products
EP1371371B1 (en) The use of n-acetyl-d-glucosamine in the manufacture of pharmaceutical useful for preventing and treating sexual disorder
JP2004504861A (en) Supplement
JPH04211017A (en) Therapeutic drug for dermatitis
US20080227869A1 (en) Substituted nitrobenzene derivatives as pharmaceutical and other uses thereof
RU2166322C2 (en) Biopreparation for bee productivity enhancement
CH633188A5 (en) MEDICINE FOR INFECTIOUS DISEASES OF THE RESPIRATORY TRACT.
JP4852218B2 (en) Alcohol metabolism promoter composition
WO2021071375A1 (en) Functional drinking water
WO2018107365A1 (en) Anaerostipes caccae and applications thereof
CS212234B2 (en) Method of making the immunotherapeutical means against the infection decease uf urine and digesting ways

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase